Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of the Endocrine Society|January 19, 2026
A Randomized Study of the Glunovo Real-time CGM Effectiveness in Individuals With Poorly Controlled Type 2 DiabetesElisa Lazzaroni, Vincenzo Cimino, Alessandra Gandolfi, et al.
Pharmacological Research|March 5, 2023
Broadening horizons in mechanisms, management, and treatment of diabetic kidney diseaseAdriana Petrazzuolo, Gianmarco Sabiu, Emma Assi, et al.
The Journal of Clinical Endocrinology and Metabolism|February 23, 2026
The use of semaglutide as an add-on therapy in patients with LADAMaria Elena Lunati, Vincenzo Cimino, Davide Bernasconi, et al.
Pharmacological Research|August 15, 2022
SGLT2-inhibitors are effective and safe in the elderly: The SOLD studyMaria Elena Lunati, Vincenzo Cimino, Alessandra Gandolfi, et al.
Acta Diabetologica|June 21, 2022
Abnormalities of the oculomotor function in type 1 diabetes and diabetic neuropathyFrancesca D'Addio, Ida Pastore, Cristian Loretelli, et al.
Pharmacological Research|December 21, 2023
Type 2 diabetes mellitus pharmacological remission with dapagliflozin plus oral semaglutideMaria Elena Lunati, Vincenzo Cimino, Davide Bernasconi, et al.
JCI Insight|November 16, 2021
PD-1 blockade counteracts post-COVID-19 immune abnormalities and stimulates the anti-SARS-CoV-2 immune responseCristian Loretelli, Ahmed Abdelsalam, Francesca D'Addio, et al.
The Journal of Clinical Endocrinology and Metabolism|July 23, 2024
Vaccinome Landscape in Nearly 620 000 Patients With DiabetesFrancesca D'Addio, Elisa Lazzaroni, Maria Elena Lunati, et al.
Diabetes|May 13, 2022
Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccines in a Cohort of Patients With Type 1 DiabetesFrancesca D'Addio, Gianmarco Sabiu, Vera Usuelli, et al.
Pharmacological Research|July 31, 2022
Dapagliflozin acutely improves kidney function in type 2 diabetes mellitus. The PRECARE studyElisa Lazzaroni, Maria Elena Lunati, Laura Montefusco, et al.
Pageof 4